Multisystemic Effects of Elexacaftor-Tezacaftor-Ivacaftor in Adults with Cystic Fibrosis and Advanced Lung Disease.
Burgel PR, Paillasseur JL, Durieu I, Reynaud-Gaubert M, Hamidfar R MD, Murris-Espin M, Danner-Boucher I, Chiron R, Leroy S, Douvry B, Grenet D, Mely L, Ramel S, Moncouquiol S, Burnet E, Ouaalaya EH, Sogni P, Da Silva J, Martin C.
Burgel PR, et al. Among authors: burnet e.
Ann Am Thorac Soc. 2024 Apr 5. doi: 10.1513/AnnalsATS.202312-1065OC. Online ahead of print.
Ann Am Thorac Soc. 2024.
PMID: 38579175